Brief: Allena Announces Completion Of Enrollment Of Cohorts A, B Of ALLN-346 Phase 2A Study 202
19/07/2022 14:37
July 19 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT
OF
COHORTS A AND B OF ALLN-346 PHASE 2A STUDY 202 IN PATIENTS WITH
GOUT AND STAGES 2 AND 3 CHRONIC KIDNEY DISEASE
Source text for Eikon: ID:nGNX73gnDz
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing